Cancers outcomes endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Endometrium Tumor Cells, Cultured Neoplastic Stem Cells Breast Lymph Nodes Prostate

Organisms2

Mice, Nude Mice, SCID

Diseases63

Vulvar Neoplasms Endometrial Neoplasms Breast Neoplasms Neoplasms Carcinoma, Endometrioid Prostatic Neoplasms Ovarian Neoplasms Lung Neoplasms Pancreatic Neoplasms Neoplasm Recurrence, Local Neoplasm Invasiveness Adenocarcinoma Colonic Neoplasms Endometrial Hyperplasia Stomach Neoplasms Colorectal Neoplasms Uterine Neoplasms Neoplasm Metastasis Urinary Bladder Neoplasms Disease Progression Carcinoma Genetic Predisposition to Disease Uterine Cervical Neoplasms Genital Neoplasms, Female Cystadenocarcinoma, Serous Neoplasms, Second Primary Neoplasms, Multiple Primary Skin Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Carcinoma, Squamous Cell Adenocarcinoma, Clear Cell Liver Neoplasms Carcinoma, Non-Small-Cell Lung Cell Transformation, Neoplastic Rectal Neoplasms Kidney Neoplasms Cystadenocarcinoma, Papillary Thyroid Neoplasms Neoplasms, Hormone-Dependent Adenocarcinoma, Mucinous Neoplasms, Radiation-Induced Neoplasms, Cystic, Mucinous, and Serous Bone Neoplasms Neoplasms, Glandular and Epithelial Gastrointestinal Neoplasms Precancerous Conditions Esophageal Neoplasms Mouth Neoplasms Adenocarcinoma, Papillary Head and Neck Neoplasms Carcinoma, Papillary Carcinoma, Pancreatic Ductal Neoplasms, Experimental Neovascularization, Pathologic Microsatellite Instability Testicular Neoplasms Adenoma Mixed Tumor, Mullerian Peritoneal Neoplasms Vaginal Neoplasms Carcinoma, Small Cell Recurrence Obesity

Chemicals and Drugs46

Tumor Markers, Biological Neoplasm Proteins Receptors, Estrogen Prostate-Specific Antigen Tamoxifen DNA, Neoplasm Antineoplastic Agents Estrogens Receptors, Progesterone Cancer Vaccines Antineoplastic Agents, Hormonal RNA, Messenger Antigens, Neoplasm Receptor, erbB-2 Progestins RNA, Small Interfering Tumor Suppressor Protein p53 Estrogen Antagonists PTEN Phosphohydrolase Paclitaxel Tumor Suppressor Proteins Estrogen Receptor alpha Cisplatin Nuclear Proteins Contraceptives, Oral Anticarcinogenic Agents DNA-Binding Proteins RNA, Neoplasm Fluorouracil MicroRNAs Antineoplastic Agents, Phytogenic Antibodies, Monoclonal Estrogen Receptor Modulators Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt Selective Estrogen Receptor Modulators Receptor, Epidermal Growth Factor Adaptor Proteins, Signal Transducing MutS Homolog 2 Protein Transcription Factors Estradiol Receptors, Androgen CA-125 Antigen Ki-67 Antigen Carcinogens TOR Serine-Threonine Kinases

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Treatment Outcome Prognosis Early Detection of Cancer Neoplasm Staging Survival Analysis Risk Factors Retrospective Studies Follow-Up Studies Survival Rate SEER Program Prospective Studies Registries Cohort Studies Risk Assessment Kaplan-Meier Estimate Disease-Free Survival Gene Expression Profiling Risk Chemotherapy, Adjuvant Prostatectomy Incidence Multivariate Analysis Case-Control Studies Hysterectomy Logistic Models Odds Ratio Predictive Value of Tests Oligonucleotide Array Sequence Analysis Mammography Reverse Transcriptase Polymerase Chain Reaction Proportional Hazards Models Immunohistochemistry Clinical Trials as Topic Radiotherapy Antineoplastic Combined Chemotherapy Protocols Mastectomy Reproducibility of Results Questionnaires Sensitivity and Specificity Neoplasm Grading Combined Modality Therapy Xenograft Model Antitumor Assays Blotting, Western Neoplasm Transplantation Pregnancy Outcome Estrogen Replacement Therapy Confidence Intervals Polymerase Chain Reaction Immunoenzyme Techniques Salpingectomy Body Mass Index Transplantation, Heterologous Molecular Targeted Therapy Lymph Node Excision Tissue Array Analysis Drug Screening Assays, Antitumor Tumor Burden Randomized Controlled Trials as Topic Radiotherapy, Adjuvant Biopsy Neoplasms, Experimental Transfection Genetic Testing Hormone Replacement Therapy Chi-Square Distribution Tomography, X-Ray Computed DNA Mutational Analysis Models, Biological Gene Knockdown Techniques Flow Cytometry Mass Screening Obesity Pilot Projects

Psychiatry and Psychology1

Phenomena and Processes49

Gene Expression Regulation, Neoplastic Risk Genetic Predisposition to Disease Odds Ratio Time Factors Postmenopause Mutation Drug Resistance, Neoplasm Genotype DNA Methylation Sensitivity and Specificity Pregnancy Outcome Cell Proliferation Germ-Line Mutation Polymorphism, Genetic Apoptosis Cell Growth Processes Cell Survival Gene Silencing Down-Regulation Body Mass Index Menopause Cell Division Dose-Response Relationship, Drug Cell Cycle Cell Movement Genes, Tumor Suppressor Promoter Regions, Genetic Microsatellite Repeats Premenopause Diet Microsatellite Instability Signal Transduction Parity Genes, Neoplasm Up-Regulation Transfection Genes, BRCA1 Base Sequence Chi-Square Distribution Alleles RNA Interference Gene Expression Phenotype Genes, p53 Pregnancy Obesity Phosphorylation Loss of Heterozygosity

Disciplines and Occupations3

Outcome Assessment (Health Care)Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena4

Quality of Life National Cancer Institute (U.S.)Socioeconomic Factors Age Distribution

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science7

Survival Rate SEER Program Registries Incidence Questionnaires Base Sequence Molecular Sequence Data

Named Groups4

European Continental Ancestry Group African Americans Survivors Hispanic Americans

Health Care43

Treatment Outcome Survival Analysis Risk Factors Retrospective Studies Follow-Up Studies Survival Rate SEER Program Prospective Studies Outcome Assessment (Health Care)Registries Cohort Studies Risk Assessment Kaplan-Meier Estimate Disease-Free Survival Risk Incidence Multivariate Analysis Case-Control Studies Logistic Models Odds Ratio Predictive Value of Tests Age Factors Proportional Hazards Models Clinical Trials as Topic Reproducibility of Results Questionnaires Sensitivity and Specificity Healthcare Disparities National Cancer Institute (U.S.)Socioeconomic Factors Confidence Intervals Body Mass Index Randomized Controlled Trials as Topic Parity Genetic Testing Chi-Square Distribution Age Distribution Confounding Factors (Epidemiology)Mass Screening Outcome and Process Assessment (Health Care)American Cancer Society Pilot Projects Comorbidity

Geographicals4

United States China Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Breast Neoplasms Treatment Outcome Neoplasms Carcinoma, Endometrioid Prostatic Neoplasms Prognosis Early Detection of Cancer Neoplasm Staging Survival Analysis Risk Factors Ovarian Neoplasms Tumor Markers, Biological Retrospective Studies Lung Neoplasms Pancreatic Neoplasms Follow-Up Studies Gene Expression Regulation, Neoplastic United States Survival Rate Neoplasm Recurrence, Local Neoplasm Invasiveness SEER Program Prospective Studies Outcome Assessment (Health Care)Registries Cohort Studies Risk Assessment Adenocarcinoma Kaplan-Meier Estimate Colonic Neoplasms Disease-Free Survival Endometrial Hyperplasia Stomach Neoplasms Colorectal Neoplasms Gene Expression Profiling Uterine Neoplasms Neoplasm Metastasis Urinary Bladder Neoplasms Neoplasm Proteins Disease Progression Risk Receptors, Estrogen Chemotherapy, Adjuvant Prostatectomy Carcinoma Incidence Cell Line, Tumor Genetic Predisposition to Disease Multivariate Analysis Case-Control Studies Prostate-Specific Antigen Hysterectomy Mice, Nude Tamoxifen Logistic Models Odds Ratio European Continental Ancestry Group Endometrium Uterine Cervical Neoplasms DNA, Neoplasm Genital Neoplasms, Female African Americans Predictive Value of Tests Time Factors Cystadenocarcinoma, Serous Oligonucleotide Array Sequence Analysis Neoplasms, Second Primary Neoplasms, Multiple Primary Mammography Antineoplastic Agents Age Factors Reverse Transcriptase Polymerase Chain Reaction Quality of Life Proportional Hazards Models Immunohistochemistry Postmenopause Clinical Trials as Topic Radiotherapy Estrogens Receptors, Progesterone Mutation Antineoplastic Combined Chemotherapy Protocols Cancer Vaccines Antineoplastic Agents, Hormonal Mastectomy Skin Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis RNA, Messenger Carcinoma, Squamous Cell Reproducibility of Results Drug Resistance, Neoplasm Genotype Questionnaires DNA Methylation Sensitivity and Specificity Neoplasm Grading Combined Modality Therapy Adenocarcinoma, Clear Cell

No FAQ available that match "cancers outcomes endometrial cancer vulvar neoplasms"